Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to $21.9 million.

  • Neurogene's Total Non-Current Liabilities fell 16.10% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year decrease of 16.10%. This contributed to the annual value of $24.6 million for FY2024, which is 30.68% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Total Non-Current Liabilities is $21.9 million, which was down 6.25% from $23.3 million recorded in Q2 2025.
  • In the past 5 years, Neurogene's Total Non-Current Liabilities registered a high of $35.5 million during Q4 2023, and its lowest value of $21.9 million during Q3 2025.
  • Over the past 3 years, Neurogene's median Total Non-Current Liabilities value was $23.9 million (recorded in 2024), while the average stood at $25.3 million.
  • Data for Neurogene's Total Non-Current Liabilities shows a maximum YoY plummeted of 30.68% (in 2024) over the last 5 years.
  • Over the past 3 years, Neurogene's Total Non-Current Liabilities (Quarterly) stood at $35.5 million in 2023, then plummeted by 30.68% to $24.6 million in 2024, then dropped by 16.10% to $21.9 million in 2025.
  • Its last three reported values are $21.9 million in Q3 2025, $23.3 million for Q2 2025, and $22.8 million during Q1 2025.